Mergers & Acquisitions XV

Published: 1 March 2013

PEOPLE

Rudolf Tschäni

Senior Counsel
Expertise

Corporate and M&A
Details

Number of pages

286 pages

Publisher

Schulthess Verlag

Language

German

Price

CHF 82.00

ISBN number

978-3-7255-6754-6

Die Beiträge des 15. M&A-Seminars, welches vom Europa Institut an der Universität Zürich (EIZ) durchgeführt wurde, stehen nun in schriftlicher Form zur Verfügung.

24 Jun 2026

Mehr Ordnung, weniger Spielraum? M&A im Wandel der Kräfteverhältnisse

in: EuropaInstitut, 28. Zürcher Konferenz Mergers & Acquisitions - Tagungsband 2025

AUTHORS
Tino Gaberthüel Matthias Wolf
Expertise

Corporate and M&A
24 Jun 2026

Von unterschiedlichen Preisvorstellungen zum erfolgreichen Deal

in: Gaberthüel/Wolf (eds.), EuropaInstitut, 28. Zürcher Konferenz Mergers & Acquisitions - Tagungsband 2025, Zürich 2026

AUTHORS
Simone Ehrsam
Expertise

Corporate and M&A

PDF

SEE ALL

Deals & Cases — 02.07.2026

Helvetia Baloise Group completes post-merger legal integration in Switzerland

Deals & Cases — 01.07.2026

Ipsen to acquire Memo Therapeutics AG

SEE ALL

Insights – 16.06.2026

New Legal Entities Transparency Act to enter into force on 1 October 2026

On 12 June 2026, the Federal Council set 1 October 2026 as the entry into force date of the Federal Act on the Transparency of Legal Entities and the Identification of Beneficial Owners (the “Legal Entities Transparency Act”, “LETA”) and its implementing Ordinance (the “Legal Entities Transparency Ordinance”, “LETO”).

Insights – 29.05.2026

Swiss Federal Supreme Court rules that shareholders have no say on asset sales in composition proceedings

Swiss Federal Supreme Court rules that shareholders have no say on asset…

The Swiss Federal Supreme Court has issued an important decision on asset sales during a composition moratorium. In essence, the court has clarified the following: - Like creditors, shareholders do not have standing to challenge a court's decision on asset sales during a composition moratorium. - If an asset sale occurs during a composition moratorium, no shareholder approval is required even if the sale relates to all or a significant part of the assets of a company. The decision removes legal uncertainty and will be helpful to structure and implement pre-pack and other asset disposal transactions under time pressure.

SEE ALL

Mergers & Acquisitions XV

Related publications

Deals & Cases

Insights